BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10100587)

  • 1. Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency.
    Toren A; Nagler A; Amariglio N; Neumann Y; Golan H; Bilori B; Kaplinsky C; Mandel M; Biniaminov M; Levanon M; Rosenthal E; Davidson J; Brok-Simoni F; Rechavi G
    Bone Marrow Transplant; 1999 Feb; 23(4):405-8. PubMed ID: 10100587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful unrelated mismatched cord blood transplantation in an infant with severe combined immunodeficiency and Mycobacterium bovis bacillus Calmette-Guèrin disease.
    Jaing TH; Lee WI; Lin TY; Huang JL; Chen SH; Chow R
    Pediatr Transplant; 2006 Jun; 10(4):501-4. PubMed ID: 16712611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome.
    Fagioli F; Biasin E; Berger M; Nesi F; Saroglia EH; Miniero R; Martino S; Tovo PA
    Bone Marrow Transplant; 2003 Jan; 31(2):133-6. PubMed ID: 12621496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful unrelated umbilical cord blood cell transplantation without conditioning for a neonate with severe combined immunodeficiency.
    Taga T; Itoh E; Noda Y; Kato H; Maruo Y; Takano T; Ohta S; Takeuchi Y; Kumaki S
    Pediatr Transplant; 2011 Nov; 15(7):E152-5. PubMed ID: 20534026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.
    Schönberger S; Ott H; Gudowius S; Wüller S; Baron JM; Merk HF; Lassay L; Megahed M; Feyen O; Laws HJ; Dilloo D; Borkhardt A; Niehues T
    Clin Immunol; 2009 Mar; 130(3):259-63. PubMed ID: 19064334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.
    Pirovano S; Notarangelo LD; Malacarne F; Mazzolari E; Porta F; Lanfranchi A; Giliani S; Zucca S; Pecorelli S; Albertini A; Ugazio AG; Imberti L
    Haematologica; 2004 Apr; 89(4):450-61. PubMed ID: 15075079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
    Goebel WS; Nelson RP; Brahmi Z; Gowan DJ; Towell PJ; Robertson KA; Haut PR
    Transplantation; 2006 Jun; 81(11):1596-9. PubMed ID: 16770250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
    Dvorak CC; Cowan MJ
    Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
    Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
    J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
    Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
    Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency.
    Bhattacharya A; Slatter MA; Chapman CE; Barge D; Jackson A; Flood TJ; Abinun M; Cant AJ; Gennery AR
    Bone Marrow Transplant; 2005 Aug; 36(4):295-9. PubMed ID: 15968287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for profound T-cell deficiency (combined immunodeficiency).
    Roifman CM
    Immunol Allergy Clin North Am; 2010 May; 30(2):209-19. PubMed ID: 20493397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.